Home Other Building Blocks VIGABATRIN

VIGABATRIN

CAS No.:
60643-86-9
Catalog Number:
AG00E8RR
Molecular Formula:
Molecular Weight:
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG00E8RR
Chemical Name:
VIGABATRIN
CAS Number:
60643-86-9
IUPAC Name:
4-aminohex-5-enoic acid
InChI:
InChI=1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9)
InChI Key:
PJDFLNIOAUIZSL-UHFFFAOYSA-N
Properties
Complexity:
112  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
129.079g/mol
Formal Charge:
0
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
129.159g/mol
Monoisotopic Mass:
129.079g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
63.3A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
-2.2  
Literature
Title Journal
Vigabatrin-induced CNS changes in juvenile rats: Induction, progression and recovery of myelin-related changes. Neurotoxicology 20150101
Valproate-related erythrodermia with reversible encephalopathy: a rare but serious adverse reaction, case report. Acta dermatovenerologica Alpina, Pannonica, et Adriatica 20140101
Evolution of visual field loss over ten years in individuals taking vigabatrin. Epilepsy research 20130801
Detection of 22 antiepileptic drugs by ultra-performance liquid chromatography coupled with tandem mass spectrometry applicable to routine therapeutic drug monitoring. Biomedical chromatography : BMC 20121201
Taurine deficiency damages retinal neurones: cone photoreceptors and retinal ganglion cells. Amino acids 20121101
Ohtahara syndrome or early-onset West syndrome? A case with overlapping features and favorable response to vigabatrin. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20121101
Vigabatrin-associated retinal damage: potential biochemical mechanisms. Acta neurologica Scandinavica 20121001
Sildenafil influences the anticonvulsant activity of vigabatrin and gabapentin in the timed pentylenetetrazole infusion test in mice. Progress in neuro-psychopharmacology & biological psychiatry 20121001
Patterns of peripapillary retinal nerve fiber layer thinning in vigabatrin-exposed individuals. Ophthalmology 20121001
The current evaluation and treatment of infantile spasms among members of the Child Neurology Society. Journal of child neurology 20121001
Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase. Bioorganic & medicinal chemistry 20121001
A randomized controlled trial of flunarizine as add-on therapy and effect on cognitive outcome in children with infantile spasms. Epilepsia 20120901
T2 hyperintense signal of the central tegmental tracts in children: disease or normal maturational process? Neuroradiology 20120801
Coexisting seizures in patients with infantile spasms confirmed by long-term video-electroencephalography monitoring. Epilepsy research 20120801
Infantile spasms: treatment challenges. Current treatment options in neurology 20120801
Visual field and ocular safety during short-term vigabatrin treatment in cocaine abusers. American journal of ophthalmology 20120801
Effect of second-generation antiepileptic drugs on diplopia: a meta-analysis of placebo-controlled studies. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20120801
Chemical properties of antiepileptic drugs (AEDs). Advanced drug delivery reviews 20120701
Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 20120612
Taurine-like GABA aminotransferase inhibitors prevent rabbit brain slices against oxygen-glucose deprivation-induced damage. Amino acids 20120601
Electroretinographic (ERG) responses in pediatric patients using vigabatrin. Documenta ophthalmologica. Advances in ophthalmology 20120601
Carrier-mediated γ-aminobutyric acid transport across the basolateral membrane of human intestinal Caco-2 cell monolayers. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120601
[Anaesthesia of epileptic patient]. Annales francaises d'anesthesie et de reanimation 20120601
Rash in psychiatric and nonpsychiatric adolescent patients receiving lamotrigine in Korea: a retrospective cohort study. Psychiatry investigation 20120601
May GABA transaminase inhibitors improve stereotyped behaviors in Rett syndrome? Amino acids 20120501
Vigabatrin for focal drug delivery in epilepsy: bilateral microinfusion into the subthalamic nucleus is more effective than intranigral or systemic administration in a rat seizure model. Neurobiology of disease 20120501
Vigabatrin-induced forced normalization and psychosis--prolongated termination of behavioral symptoms but persistent antiepileptic effect after withdrawal. Epilepsy & behavior : E&B 20120501
Outcomes of epileptic spasms in patients aged less than 3 years: single-center United States experience. Pediatric neurology 20120501
Acute and subchronic toxicological evaluation of Echinophora platyloba DC (Apiaceae) total extract in Wistar rats. Clinics (Sao Paulo, Brazil) 20120501
Rectal absorption of vigabatrin, a substrate of the proton coupled amino acid transporter (PAT1, Slc36a1), in rats. Pharmaceutical research 20120401
Effects of vigabatrin, an irreversible GABA transaminase inhibitor, on ethanol reinforcement and ethanol discriminative stimuli in mice. Behavioural pharmacology 20120401
Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations. CNS drugs 20120401
[Pharmacological treatment of spasticity in multiple sclerosis]. Revue neurologique 20120401
Vigabatrin monotherapy for infantile spasms. Expert review of neurotherapeutics 20120301
Prevalence of treated epilepsy in Korea based on national health insurance data. Journal of Korean medical science 20120301
Interactions of pregabalin with gabapentin, levetiracetam, tiagabine and vigabatrin in the mouse maximal electroshock-induced seizure model: a type II isobolographic analysis. Epilepsy research 20120201
Retinal and cochlear toxicity of drugs: new insights into mechanisms and detection. Current opinion in neurology 20120201
[Enriched-enrollment randomized-withdrawal trials]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20120201
Vigabatrin for childhood partial-onset epilepsies. Pediatric neurology 20120201
Historic, clinical, and prognostic features of epileptic encephalopathies caused by CDKL5 mutations. Pediatric neurology 20120201
The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms. Journal of medicinal chemistry 20120126
Vigabatrin versus carbamazepine monotherapy for epilepsy. The Cochrane database of systematic reviews 20120118
(1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addiction. Journal of medicinal chemistry 20120112
Clavulanic acid does not affect convulsions in acute seizure tests in mice. Journal of neural transmission (Vienna, Austria : 1996) 20120101
Use of the modified Atkins diet in infantile spasms refractory to first-line treatment. Seizure 20120101
Mitochondrial toxicity of antiepileptic drugs and their tolerability in mitochondrial disorders. Expert opinion on drug metabolism & toxicology 20120101
GABA expression and regulation by sensory experience in the developing visual system. PloS one 20120101
Weight-reducing side effects of the antiepileptic agents topiramate and zonisamide. Handbook of experimental pharmacology 20120101
Parallel mapping and simultaneous sequencing reveals deletions in BCAN and FAM83H associated with discrete inherited disorders in a domestic dog breed. PLoS genetics 20120101
Topiramate and the vision: a systematic review. Clinical ophthalmology (Auckland, N.Z.) 20120101
Clinical utility of adjunctive retigabine in partial onset seizures in adults. Therapeutics and clinical risk management 20120101
GABA Not Only a Neurotransmitter: Osmotic Regulation by GABA(A)R Signaling. Frontiers in cellular neuroscience 20120101
A microdialysis study of oral vigabatrin administration in head injury patients: preliminary evaluation of multimodality monitoring. Acta neurochirurgica. Supplement 20120101
Forty-year-old diabetic lady with tightness in lower limbs. Annals of Indian Academy of Neurology 20120101
[Pregabalin--a drug with abuse potential?]. Archiv fur Kriminologie 20120101
Epilepsy as a neurodevelopmental disorder. Frontiers in psychiatry 20120101
Zimelidine attenuates the development of tolerance to morphine-induced antinociception. Indian journal of pharmacology 20120101
GABA metabolism and transport: effects on synaptic efficacy. Neural plasticity 20120101
Acute and 28-Day Subchronic Oral Toxicity of an Ethanol Extract of Zingiber zerumbet (L.) Smith in Rodents. Evidence-based complementary and alternative medicine : eCAM 20120101
Salicylate toxicity model of tinnitus. Frontiers in systems neuroscience 20120101
Effects of vigabatrin on the skeletal system of young rats. Acta poloniae pharmaceutica 20120101
Pharmacological management of binge eating disorder: current and emerging treatment options. Therapeutics and clinical risk management 20120101
Vigabatrin-associated visual field loss. International ophthalmology clinics 20120101
Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents. BMC pediatrics 20120101
Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors. PloS one 20120101
[The course and treatment of epilepsy in children with tuberose sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20120101
New developments in the treatment of partial-onset epilepsy. Neuropsychiatric disease and treatment 20120101
A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 20120101
Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide. CNS drugs 20111205
Oral toxicity of vigabatrin in immature rats: characterization of intramyelinic edema. Neurotoxicology 20111201
The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport. British journal of pharmacology 20111201
Activity-dependent γ-aminobutyric acid release controls brain cortical tissue slice metabolism. Journal of neuroscience research 20111201
Early age conductive hearing loss causes audiogenic seizure and hyperacusis behavior. Hearing research 20111201
Transition to absence seizures and the role of GABA(A) receptors. Epilepsy research 20111201
Registry initiated to characterize vision loss associated with vigabatrin therapy. Epilepsy & behavior : E&B 20111201
Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. Epilepsy & behavior : E&B 20111201
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology 20111201
Clinical progress of epilepsy in children with tuberous sclerosis: prognostic factors for seizure outcome. Chonnam medical journal 20111201
Experimental panic provocation in healthy man-a translational role in anti-panic drug development? Dialogues in clinical neuroscience 20111201
Treatment of West syndrome with vigabatrin: reversible MRI signal changes. Arquivos de neuro-psiquiatria 20111201
Enhanced GABAergic tone in the ventral pallidum: memory of unpleasant experiences? Neuroscience 20111124
Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity. Behavioural brain research 20111120
Mechanisms of GABA release from human astrocytes. Glia 20111101
Medication neurotoxicity in children. Pediatric radiology 20111101
Screening for vigabatrin (Sabril ®) retinal toxicity in children. Ophthalmic genetics 20111101
Fundal changes in children receiving Vigabatrin. Indian journal of pediatrics 20111001
Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology. Brain : a journal of neurology 20111001
Sensitivity and specificity of retinal nerve fiber layer thinning to detect visual field loss from vigabatrin. Annals of neurology 20111001
Measuring field loss in children administered vigabatrin: a problem in search of a solution. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20111001
Modelling the topography of absolute defects in patients exposed to the anti-epileptic drug vigabatrin and in normal subjects using automated static suprathreshold perimetry of the entire 80° visual field. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20110901
Carisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasms. Epilepsia 20110901
[Aicardi syndrome associated with severe congenital ptosis]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20110901
Validation of the rat model of cryptogenic infantile spasms. Epilepsia 20110901
Angelman syndrome and pseudo-hypsarrhythmia: a diagnostic pitfall. Epileptic disorders : international epilepsy journal with videotape 20110901
Psychiatric symptoms and quality of life in patients with drug-refractory epilepsy receiving adjunctive levetiracetam therapy. Journal of clinical neurology (Seoul, Korea) 20110901
Short term outcomes of topiramate monotherapy as a first-line treatment in newly diagnosed West syndrome. Korean journal of pediatrics 20110901
GABAergic neural activity involved in salicylate-induced auditory cortex gain enhancement. Neuroscience 20110825
Retinal nerve fibre layer attenuation: clinical indicator for vigabatrin toxicity. Acta ophthalmologica 20110801
Treatment options in juvenile myoclonic epilepsy. Current treatment options in neurology 20110801
A pulse rapamycin therapy for infantile spasms and associated cognitive decline. Neurobiology of disease 20110801
Antiepileptic drug discovery: does mechanism of action matter? Epilepsy & behavior : E&B 20110801
Gabapentin: An update of its pharmacological properties and therapeutic use in epilepsy. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20110801
Gender-specific effect of Mthfr genotype and neonatal vigabatrin interaction on synaptic proteins in mouse cortex. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110701
The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study. Epilepsia 20110701
Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addiction science & clinical practice 20110701
Inhalant use and inhalant use disorders in the United States. Addiction science & clinical practice 20110701
Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials. CNS neuroscience & therapeutics 20110601
Electroretinogram changes in a pediatric population with epilepsy: is vigabatrin acting alone? Journal of child neurology 20110601
Paediatric post-marketing pharmacovigilance: comparison of the adverse event profile of vigabatrin prescribed to children and adults. Pharmacoepidemiology and drug safety 20110601
Diagnosis and management of glutaric aciduria type I--revised recommendations. Journal of inherited metabolic disease 20110601
Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date. Current genomics 20110601
Precolumn derivatization followed by liquid chromatographic separation and determination of tramiprosate in rat plasma by fluorescence detector: application to pharmacokinetics. Journal of pharmaceutical and biomedical analysis 20110515
Effects of GABA-transaminase inhibitor Vigabatrin on thermoregulation in rats. Amino acids 20110501
Reversible magnetic resonance imaging and spectroscopy abnormalities in the course of vigabatrin treatment for West syndrome. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20110501
Retinal nerve fiber layer thickness in vigabatrin-exposed patients. Annals of neurology 20110501
Magnetic resonance spectroscopy studies of human metabolism. Diabetes 20110501
Antiepileptic drugs and the immune system. Epilepsia 20110501
Drug resistance in epilepsy and the ABCB1 gene: The clinical perspective. Indian journal of human genetics 20110501
Seizure outcome in infantile spasms--a retrospective study. Epilepsia 20110401
Epilepsy: Vigabatrin treatment and visual field loss. Nature reviews. Neurology 20110401
Non-neuronal, slow GABA signalling in the ventrobasal thalamus targets δ-subunit-containing GABA(A) receptors. The European journal of neuroscience 20110401
A substituted anilino enaminone acts as a novel positive allosteric modulator of GABA(A) receptors in the mouse brain. The Journal of pharmacology and experimental therapeutics 20110301
Vigabatrin for infantile spasms. Pharmacotherapy 20110301
Depressogenic effects of medications: a review. Dialogues in clinical neuroscience 20110301
Gaboxadol has affinity for the proton-coupled amino acid transporter 1, SLC36A1 (hPAT1)--A modelling approach to determine IC(50) values of the three ionic species of gaboxadol. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20110214
Knockout of GAD65 has major impact on synaptic GABA synthesized from astrocyte-derived glutamine. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20110201
Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (DEND) syndrome and a novel ABCC8 gene mutation. Diabetologia 20110201
Anesthetic experience of a patient with Ohtahara syndrome -A case report-. Korean journal of anesthesiology 20110201
An historical perspective on GABAergic drugs. Future medicinal chemistry 20110201
Sex-dependent behavioral effects of Mthfr deficiency and neonatal GABA potentiation in mice. Behavioural brain research 20110120
[West syndrome: aetiology, therapeutic options, clinical course and prognostic factors]. Revista de neurologia 20110116
Abnormal axial diffusivity in the deep gray nuclei and dorsal brain stem in infantile spasm treated with vigabatrin. AJNR. American journal of neuroradiology 20110101
Astrocytes are GABAergic cells that modulate microglial activity. Glia 20110101
Mutations and deletions in PCDH19 account for various familial or isolated epilepsies in females. Human mutation 20110101
Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis. Archives of neurology 20110101
Electrophysiological evaluation of retinal function in children receiving vigabatrin medication. Journal of pediatric ophthalmology and strabismus 20110101
Visual fields in neuro-ophthalmology. Indian journal of ophthalmology 20110101
[Compassionate use of vigabatrin for intractable epilepsy in Japan]. No to hattatsu = Brain and development 20110101
Transcriptomic analysis in a Drosophila model identifies previously implicated and novel pathways in the therapeutic mechanism in neuropsychiatric disorders. Frontiers in neuroscience 20110101
Epilepsy (partial). BMJ clinical evidence 20110101
4-aminobutyrate aminotransferase (ABAT): genetic and pharmacological evidence for an involvement in gastro esophageal reflux disease. PloS one 20110101
Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey. BMC pediatrics 20110101
Management of provoked seizure. Annals of Indian Academy of Neurology 20110101
Utility of certain nucleophilic aromatic substitution reactions for the assay of pregabalin in capsules. Chemistry Central journal 20110101
The effect of gabapentin on gap detection and forward masking in young and old gerbils. Ear and hearing 20110101
Suicidal behavior and antiepileptic drugs in epilepsy: analysis of the emerging evidence. Drug, healthcare and patient safety 20110101
Sensitive and selective spectrophotometric determination of gabapentin in capsules using two nitrophenols as chromogenic agents. International journal of analytical chemistry 20110101
Clinical uses of melatonin in pediatrics. International journal of pediatrics 20110101
Evaluation of Heart Rate Variation Analysis during Rest and Tilting in Patients with Temporal Lobe Epilepsy. Neurology research international 20110101
An integrative view of mechanisms underlying generalized spike-and-wave epileptic seizures and its implication on optimal therapeutic treatments. PloS one 20110101
Altered GABA signaling in early life epilepsies. Neural plasticity 20110101
Augmentation of Tonic GABA(A) Inhibition in Absence Epilepsy: Therapeutic Value of Inverse Agonists at Extrasynaptic GABA(A) Receptors. Advances in pharmacological sciences 20110101
Treatment options for refractory and difficult to treat seizures: focus on vigabatrin. Therapeutics and clinical risk management 20110101
Lamotrigine-induced SIADH in a child with central diabetes insipidus. Journal of pediatric neurosciences 20110101
A novel method for spectrophotometric determination of pregabalin in pure form and in capsules. Chemistry Central journal 20110101
Phenytoin-induced gingival overgrowth: a review of the molecular, immune, and inflammatory features. ISRN dentistry 20110101
Prenatal VPA Exposure and Changes in Sensory Processing by the Superior Colliculus. Frontiers in integrative neuroscience 20110101
Severe myoclonic epilepsy of infancy (Dravet syndrome): Clinical and genetic features of nine Turkish patients. Annals of Indian Academy of Neurology 20110101
Novel pharmacotherapeutic treatments for cocaine addiction. BMC medicine 20110101
Vigabatrin 35 years later - from mechanism of action to benefit-risk considerations. Acta neurologica Scandinavica. Supplementum 20110101
Mechanism of action of vigabatrin: correcting misperceptions. Acta neurologica Scandinavica. Supplementum 20110101
Vigabatrin therapy for refractory complex partial seizures: review of major European trials. Acta neurologica Scandinavica. Supplementum 20110101
Vigabatrin therapy for refractory complex partial seizures: review of clinical trial experience in the United States. Acta neurologica Scandinavica. Supplementum 20110101
Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing. Acta neurologica Scandinavica. Supplementum 20110101
Primer on visual field testing, electroretinography, and other visual assessments for patients treated with vigabatrin. Acta neurologica Scandinavica. Supplementum 20110101
Understanding and interpreting vision safety issues with vigabatrin therapy. Acta neurologica Scandinavica. Supplementum 20110101
Non-vision adverse events with vigabatrin therapy. Acta neurologica Scandinavica. Supplementum 20110101
Balancing clinical benefits of vigabatrin with its associated risk of vision loss. Acta neurologica Scandinavica. Supplementum 20110101
Effect of Gentiana olivieri on experimental epilepsy models. Pharmacognosy magazine 20110101
Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy and PEHO-like syndrome: Report of two cases. Journal of pediatric neurosciences 20110101
MRI changes associated with vigabatrin treatment mimicking tumor progression. Pediatric blood & cancer 20101201
Vigabatrin-associated diffusion MRI abnormalities in tuberous sclerosis. Pediatric radiology 20101201
Comparative anticonvulsant efficacy in the corneal kindled mouse model of partial epilepsy: Correlation with other seizure and epilepsy models. Epilepsy research 20101201
Vigabatrin-induced peripheral visual field defects in patients with refractory partial epilepsy. Epilepsy research 20101201
Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review. Epilepsia 20101201
New drugs for pediatric epilepsy. Seminars in pediatric neurology 20101201
Use of antiepileptic drugs for hyperkinetic movement disorders. Current neuropharmacology 20101201
'Epileptic encephalopathy' of infancy and childhood: electro-clinical pictures and recent understandings. Current neuropharmacology 20101201
[Epileptic spasms without hypsarrhythmia. A new case report and review of the literature]. Revista de neurologia 20101116
Vigabatrin for the treatment of infantile spasms: final report of a randomized trial. Journal of child neurology 20101101
Recommendations for visual evaluations of patients treated with vigabatrin. Current opinion in ophthalmology 20101101
Is reduced ornithine-δ-aminotransferase activity the cause of vigabatrin-associated visual field defects? Epilepsy research 20101101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Vigabatrin administration in patients with infantile spasms: the risks. Clinical neurology and neurosurgery 20101101
Assessing the unmet treatment need in partial-onset epilepsy: looking beyond seizure control. Epilepsia 20101101
[Effectiveness of vigabatrin in west syndrome associated with tuberous sclerosis]. No to hattatsu = Brain and development 20101101
Infantile spasms: a U.S. consensus report. Epilepsia 20101001
γ-Hydroxybutyrate and the GABAergic footprint: a metabolomic approach to unpicking the actions of GHB. Journal of neurochemistry 20101001
Infantile spasms: toward a selective diagnostic and therapeutic approach. Epilepsia 20101001
The Japanese scheme of ACTH therapy in West syndrome. Epilepsia 20101001
The proton-coupled amino acid transporter, SLC36A1 (hPAT1), transports Gly-Gly, Gly-Sar and other Gly-Gly mimetics. British journal of pharmacology 20101001
A European perspective—comments on 'Infantile spasms: a U.S. consensus report'. Epilepsia 20101001
Simultaneous HPLC-F analysis of three recent antiepileptic drugs in human plasma. Journal of pharmaceutical and biomedical analysis 20100921
Early infantile epileptic encephalopathy with unusual favourable outcome. Brain & development 20100901
Region-specific changes in gene expression in rat brain after chronic treatment with levetiracetam or phenytoin. Epilepsia 20100901
Maternal uniparental isodisomy is responsible for serious molybdenum cofactor deficiency. Developmental medicine and child neurology 20100901
Coexistence of cerebral tubers with neurocysticercosis. Southern medical journal 20100901
Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLoS computational biology 20100901
Antiepileptic drug interactions - principles and clinical implications. Current neuropharmacology 20100901
A high-performance liquid chromatography assay to monitor the new antiepileptic drug lacosamide in patients with epilepsy. Therapeutic drug monitoring 20100801
Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia 20100801
Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology 20100727
ACS chemical neuroscience molecule spotlight on Sabril. ACS chemical neuroscience 20100721
Vigabatrin: an antiepileptic drug with major benefits but significant adverse effects. Current drug safety 20100702
Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms. Epilepsia 20100701
Update on anticonvulsant drugs. Current neurology and neuroscience reports 20100701
Modeling new therapies for infantile spasms. Epilepsia 20100701
Visual fields in children exposed to vigabatrin in infancy. Epilepsia 20100701
Can we change the course of epilepsy in tuberous sclerosis complex? Epilepsia 20100701
New antiepileptic drugs: lacosamide, rufinamide, and vigabatrin. Current treatment options in neurology 20100701
Epilepsy (partial). BMJ clinical evidence 20100628
Vigabatrin (VGB) administered during late gestation lowers maternal folate concentration and causes pregnancy loss, fetal growth restriction and skeletal hypoplasia in the mouse. Reproductive toxicology (Elmsford, N.Y.) 20100601
Predictors of suicidal ideation in people with epilepsy living in Korea. Journal of clinical neurology (Seoul, Korea) 20100601
Meta-regression with partial information on summary trial or patient characteristics. Statistics in medicine 20100530
Placebo effects in neurological diseases. Journal of medicine and life 20100515
Renal stone associated with the ketogenic diet in a 5-year old girl with intractable epilepsy. Yonsei medical journal 20100501
[Antiepileptic drugs in North America]. Brain and nerve = Shinkei kenkyu no shinpo 20100501
Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial. Archives of disease in childhood 20100501
A sensitive period of mice inhibitory system to neonatal GABA enhancement by vigabatrin is brain region dependent. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20100401
Therapy of infantile spasms: new opportunities and emerging challenges. Epilepsy & behavior : E&B 20100401
Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats. Molecular and cellular neurosciences 20100401
Treatment and long term outcome in West syndrome: the clinical reality. A multicentre follow up study. Seizure 20100401
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20100301
Vigabatrin but not valproate prevents development of age-specific flexion seizures induced by N-methyl-D-aspartate (NMDA) in immature rats. Epilepsia 20100301
A model of symptomatic infantile spasms syndrome. Neurobiology of disease 20100301
Gamma-vinyl GABA increases nonvesicular release of GABA and glutamate in the nucleus accumbens in rats via action on anion channels and GABA transporters. Psychopharmacology 20100301
Infantile spasms. The neurologist 20100301
Vigabatrin (Sabril) for epilepsy. The Medical letter on drugs and therapeutics 20100222
[Succinic semialdehyde dehydrogenase deficiency: decrease in 4-OH-butyric acid levels with low doses of vigabatrin]. Anales de pediatria (Barcelona, Spain : 2003) 20100201
A new case of GABA transaminase deficiency facilitated by proton MR spectroscopy. Journal of inherited metabolic disease 20100201
Behavioral and cognitive effects of anti-epileptic drugs. Discovery medicine 20100201
Effects of poly-gamma-glutamic acid on serum and brain concentrations of glutamate and GABA in diet-induced obese rats. Nutrition research and practice 20100201
Infantile spasms: who are the ideal surgical candidates? Epilepsia 20100201
Favourable prognostic factors with infantile spasms. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20100101
Delayed, rapid visual field loss in a patient after ten years of vigabatrin therapy. Eye (London, England) 20100101
Management of West syndrome in a patient with methylmalonic aciduria. Journal of child neurology 20100101
Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert review of neurotherapeutics 20100101
Role of antiepileptic drugs as preventive agents for migraine. CNS drugs 20100101
Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective. BMC pediatrics 20100101
Detecting retinal vigabatrin toxicity in patients with partial symptomatic or cryptogenic epilepsy. European journal of ophthalmology 20100101
[Therapeutic drug monitoring of vigabatrin]. Therapie 20100101
Medications acting on the GABA system in the treatment of alcoholic patients. Current pharmaceutical design 20100101
Recurrent schizophrenia-like psychosis as first manifestation of epilepsy: a diagnostic challenge in neuropsychiatry. Neuropsychiatric disease and treatment 20100101
New drugs: pitavastatin calcium, vigabatrin, and romidepsin. Journal of the American Pharmacists Association : JAPhA 20100101
Management of refractory complex partial seizures: current state of the art. Neuropsychiatric disease and treatment 20100101
GABAB receptors in addiction and its treatment. Advances in pharmacology (San Diego, Calif.) 20100101
Selected Gamma Aminobutyric Acid (GABA) Esters may Provide Analgesia for Some Central Pain Conditions. Perspectives in medicinal chemistry 20100101
Influence of GABA-acting drugs on morphine-induced hyperthermia in rats. Methods and findings in experimental and clinical pharmacology 20100101
A de novo marker chromosome derived from 9p in a patient with 9p partial duplication syndrome and autism features: genotype-phenotype correlation. BMC medical genetics 20100101
Infantile scurvy: two case reports. International journal of pediatrics 20100101
Bioassay-guided evaluation of antinociceptive effect of N-salicyloyltryptamine: a behavioral and electrophysiological approach. Journal of biomedicine & biotechnology 20100101
Molecular basis for the dosing time-dependency of anti-allodynic effects of gabapentin in a mouse model of neuropathic pain. Molecular pain 20100101
Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study. Neuropsychiatric disease and treatment 20100101
Update on treatment of partial onset epilepsy: role of eslicarbazepine. Neuropsychiatric disease and treatment 20100101
Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms. Neuropsychiatric disease and treatment 20100101
Selected pharmacokinetic issues of the use of antiepileptic drugs and parenteral nutrition in critically ill patients. Nutrition journal 20100101
Development and validation of HPLC method for the determination of pregabalin in capsules. Indian journal of pharmaceutical sciences 20100101
Two female siblings with West syndrome: Familial idiopathic West syndrome with genetic susceptibility and variable phenotypic expression. Journal of pediatric neurosciences 20100101
Antiepileptic drugs and suicidality. Drug, healthcare and patient safety 20100101
Determination of pregabalin in human plasma by electrospray ionisation tandem mass spectroscopy. Journal of advanced pharmaceutical technology & research 20100101
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine. Clinical pharmacology : advances and applications 20100101
Vigabatrin. Profiles of drug substances, excipients, and related methodology 20100101
Pathological evidence of vacuolar myelinopathy in a child following vigabatrin administration. Journal of child neurology 20091201
Visual impairment at large eccentricity in participants treated by vigabatrin: visual, attentional or recognition deficit? Epilepsy research 20091201
Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations. Expert review of neurotherapeutics 20091201
Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval. Expert opinion on pharmacotherapy 20091201
Tuberous sclerosis with homonymous hemianopsia. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20091201
Zonisamide in West syndrome: an open label study. Epileptic disorders : international epilepsy journal with videotape 20091201
Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees. The American journal of psychiatry 20091101
The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent volunteers. Pharmacology, biochemistry, and behavior 20091101
Binasal visual field defects are not specific to vigabatrin. Epilepsy & behavior : E&B 20091101
Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study. CNS drugs 20091101
Expanding treatment options for cocaine dependence. The American journal of psychiatry 20091101
Drug approved to treat infantile spasms. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20091001
Basal ganglia neuroprotection with anticonvulsants after energy stress: a comparative study. Metabolic brain disease 20090901
Evaluating risks for vigabatrin treatment. Epilepsy currents 20090901
A direct HPLC method for the resolution and quantitation of the R-(-)- and S-(+)-enantiomers of vigabatrin (gamma-vinyl-GABA) in pharmaceutical dosage forms using teicoplanin aglycone chiral stationary phase. Journal of pharmaceutical and biomedical analysis 20090815
Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy. Investigative ophthalmology & visual science 20090801
Dose-related changes in retinal function and PKC-alpha expression in rabbits on vigabatrin medication. Effect of vigabatrin in the rabbit eye. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20090801
Vigabatrin attenuates the development and expression of tolerance to morphine-induced antinociception in mice. Pharmacology, biochemistry, and behavior 20090801
Is the risk of vigabatrin-attributed visual field loss lower in infancy than in later life? Epilepsia 20090801
Vigabatrin therapy in infantile spasms: solving one problem and inducing another? Epilepsia 20090801
Unilateral eyelid angiofibroma with complete blepharoptosis as the presenting sign of tuberous sclerosis. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20090801
Visual fields in young children treated with vigabatrin. Optometry and vision science : official publication of the American Academy of Optometry 20090601
Defining Meyer's loop-temporal lobe resections, visual field deficits and diffusion tensor tractography. Brain : a journal of neurology 20090601
Infantile spasms and Down syndrome: a new animal model. Pediatric research 20090501
Benign familial neonatal convulsions: novel mutation in a newborn. Pediatric neurology 20090501
A retrospective study on aetiology based outcome of infantile spasms. Seizure 20090401
Cholecystokinin-8 sulfate modulates the anticonvulsant efficacy of vigabatrin in an experimental model of partial complex epilepsy in the rat. Epilepsia 20090401
Genetic basis for idiosyncratic reactions to antiepileptic drugs. Current opinion in neurology 20090401
Biochemical characterization, mitochondrial localization, expression, and potential functions for an Arabidopsis gamma-aminobutyrate transaminase that utilizes both pyruvate and glyoxylate. Journal of experimental botany 20090401
Multicenter long-term follow-up of children with idiopathic West syndrome: ACTH versus vigabatrin. European journal of neurology 20090401
Presumed topiramate-induced maculopathy. Epilepsy & behavior : E&B 20090301
Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis. European journal of pharmacology 20090301
Nasal retinal nerve fiber layer attenuation: a biomarker for vigabatrin toxicity. Ophthalmology 20090301
Elevated endogenous GABA concentration attenuates glutamate-glutamine cycling between neurons and astroglia. Journal of neural transmission (Vienna, Austria : 1996) 20090301
Transient brain magnetic resonance imaging hyperintensity in basal ganglia and brain stem of epileptic infants treated with vigabatrin. Journal of child neurology 20090301
In utero exposure to vigabatrin: no indication of visual field loss. Epilepsia 20090201
Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia 20090201
Infantile spasms in tuberous sclerosis complex: prognostic utility of EEG. Epilepsia 20090201
Justification of vigabatrin administration in West syndrome patients? Warranting a re-consideration for improvement in their quality of life. Clinical neurology and neurosurgery 20090201
The carnitine transporter SLC22A5 is not a general drug transporter, but it efficiently translocates mildronate. Drug metabolism and disposition: the biological fate of chemicals 20090201
Racemic gamma vinyl-GABA (R,S-GVG) blocks methamphetamine-triggered reinstatement of conditioned place preference. Synapse (New York, N.Y.) 20090201
Vigabatrin extracellular pharmacokinetics and concurrent gamma-aminobutyric acid neurotransmitter effects in rat frontal cortex and hippocampus using microdialysis. Epilepsia 20090201
Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy. Epilepsia 20090201
Treatment of infantile spasms in tuberous sclerosis complex: dismal outcomes but future hope? Nature clinical practice. Neurology 20090201
Visual fields at school-age in children treated with vigabatrin in infancy. Epilepsia 20090201
Vigabatrin: 2008 update. Epilepsia 20090201
Epilepsy. BMJ clinical evidence 20090128
Simultaneous determination of three anticonvulsants using hydrophilic interaction LC-MS. Journal of separation science 20090101
Retraction and remodeling of rod spherules are early events following experimental retinal detachment: an ultrastructural study using serial sections. Molecular vision 20090101
[The contribution of magnetic resonance imaging to the diagnosis of type I glutaric aciduria]. Revista de neurologia 20090101
A Drosophila systems model of pentylenetetrazole induced locomotor plasticity responsive to antiepileptic drugs. BMC systems biology 20090101
Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity. Annals of neurology 20090101
Poisoning pyridoxal 5-phosphate-dependent enzymes: a new strategy to target the malaria parasite Plasmodium falciparum. PloS one 20090101
Influence of agmatine on the protective action of numerous antiepileptic drugs against pentetrazole-induced seizures in mice. Pharmacological reports : PR 20090101
[Ophthalmological monitoring protocol for patients treated with long-term antimalarials or vigabatrin]. Journal francais d'ophtalmologie 20090101
Onset of action and seizure control in Lennox-Gaustaut syndrome: focus on rufinamide. Therapeutics and clinical risk management 20090101
Current trends in the treatment of infantile spasms. Neuropsychiatric disease and treatment 20090101
Glutamate uptake triggers transporter-mediated GABA release from astrocytes. PloS one 20090101
Treatment of Tardive Dyskinesia by tetrabenazine, clonazepam and vitamin E. Indian journal of psychiatry 20090101
Autism and mental retardation with convulsion in tuberous sclerosis: a case report. Cases journal 20090101
Symptomatic hypocalcemia in an epileptic child treated with valproic acid plus lamotrigine: a case report. Cases journal 20090101
Postnatal onset of severe growth retardation after in utero exposure to carbamazepine and phenobarbital: a case report. Journal of medical case reports 20090101
Treatment of refractory complex partial seizures: role of vigabatrin. Neuropsychiatric disease and treatment 20090101
Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide. Neuropsychiatric disease and treatment 20090101
Pediatric migraine. International journal of pediatrics 20090101
ATP signalling in epilepsy. Purinergic signalling 20081201
Lamotrigine monotherapy for newly diagnosed typical absence seizures in children. Epilepsy research 20081201
Treatment of Lennox-Gastaut syndrome: overview and recent findings. Neuropsychiatric disease and treatment 20081201
Pregabalin for the management of partial epilepsy. Neuropsychiatric disease and treatment 20081201
Cross-sensitivity of skin rashes with antiepileptic drug use. Neurology 20081104
Subchronic racemic gamma vinyl-GABA produces weight loss in Sprague Dawley and Zucker fatty rats. Synapse (New York, N.Y.) 20081101
Isobolographic and behavioral characterizations of interactions between vigabatrin and gabapentin in two experimental models of epilepsy. European journal of pharmacology 20081024
Treatment of infantile spasms. The Cochrane database of systematic reviews 20081008
Gamma-vinyl GABA inhibits cocaine-triggered reinstatement of drug-seeking behavior in rats by a non-dopaminergic mechanism. Drug and alcohol dependence 20081001
New antiepileptic drugs in pediatric epilepsy. Brain & development 20081001
[Seizure exacerbation caused by antiepileptic drugs]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20080925
Full-field ERG and visual fields in patients 5 years after discontinuing vigabatrin therapy. Documenta ophthalmologica. Advances in ophthalmology 20080901
The ocular side effects of vigabatrin (Sabril): information and guidance for screening. Eye (London, England) 20080901
Cognitive effects of antiepileptic drugs. Journal of clinical neurology (Seoul, Korea) 20080901
Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS medicine 20080801
Drug interactions between chemotherapeutic regimens and antiepileptics. Clinical therapeutics 20080801
Vigabatrin for refractory partial epilepsy. The Cochrane database of systematic reviews 20080716
Imaging dopamine release with Positron Emission Tomography (PET) and (11)C-raclopride in freely moving animals. NeuroImage 20080701
Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile. Epilepsia 20080701
Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Epilepsia 20080701
Vigabatrin, lamotrigine, topiramate and serum carnitine levels. Pediatric neurology 20080701
The management of infantile spasms. Archives of disease in childhood 20080601
Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia : an international journal of headache 20080601
The search for medications to treat stimulant dependence. Addiction science & clinical practice 20080601
Regulation of cardiac sympathetic afferent reflex by GABA(A) and GABA(B) receptors in paraventricular nucleus in rats. The European journal of neuroscience 20080601
Subchronic treatment with antiepileptic drugs modifies pentylenetetrazol-induced seizures in mice: Its correlation with benzodiazepine receptor binding. Neuropsychiatric disease and treatment 20080601
Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20080516
New treatments for cocaine dependence: a focused review. The international journal of neuropsychopharmacology 20080501
Management of infantile spasms in a regional centre before and after the United Kingdom infantile spasms study (UKISS). Archives of disease in childhood 20080501
Liquid chromatographic resolution of vigabatrin and its analogue gamma-amino acids on chiral stationary phases based on (+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid. Journal of chromatography. A 20080425
Retinal nerve fibre layer characteristics with vigabatrin-associated visual field loss--could scanning laser polarimetry aid diagnosis? Eye (London, England) 20080401
[Current pharmacotherapies and immunotherapy in cocaine addiction]. Presse medicale (Paris, France : 1983) 20080401
Clinical picture of EPM1-Unverricht-Lundborg disease. Epilepsia 20080401
Treatment of epilepsy: the GABA-transaminase inhibitor, vigabatrin, induces neuronal plasticity in the mouse retina. The European journal of neuroscience 20080401
Intrauterine growth restriction and skeletal variations in mouse fetuses induced by vigabatrin administered at preimplantation stages of development. Congenital anomalies 20080301
Management of epilepsy in tuberous sclerosis complex. Expert review of neurotherapeutics 20080301
Pregnancy, epilepsy, and anticonvulsants. Dialogues in clinical neuroscience 20080301
The effectiveness of anticonvulsants in psychiatric disorders. Dialogues in clinical neuroscience 20080301
Inhibition of human aromatase complex (CYP19) by antiepileptic drugs. Toxicology in vitro : an international journal published in association with BIBRA 20080201
Impaired synaptogenesis and long-term modulation of behavior following postnatal elevation of GABA levels in mice. Neuropharmacology 20080201
Antiepileptic drugs and brain maturation: fetal exposure to lamotrigine generates cortical malformations in rats. Epilepsy research 20080201
[Epileptic seizures in childhood: from seizure type to diagnosis]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20080201
Fluorescent high-performance liquid chromatographic analysis of vigabatrin enantiomers after derivatizing with naproxen acyl chloride. Journal of chromatography. A 20080118
Drug-choice in management of West syndrome (infantile spasms): Early ACTH treatment may offer a better prognostic outcome. Medical hypotheses 20080101
Visual field severity indices demonstrate dose-dependent visual loss from vigabatrin therapy. Epilepsia 20080101
Vigabatrin and epilepsy: further lessons in early childhood. Epilepsia 20080101
Neonatal DSP-4 treatment modifies GABAergic neurotransmission in the prefrontal cortex of adult rats. Neurotoxicity research 20080101
Use of second-generation antiepileptic drugs in the pediatric population. Paediatric drugs 20080101
Vigabatrin-induced visual dysfunction in Chinese patients with refractory epilepsy. European journal of ophthalmology 20080101
Dose-response relationship analysis of vigabatrin doses and their antinociceptive effects in the hot-plate test in mice. Pharmacological reports : PR 20080101
Depressive symptoms in epilepsy: prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs. Drugs 20080101
CNS adverse events associated with antiepileptic drugs. CNS drugs 20080101
Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC neurology 20080101
Mutants of GABA transaminase (POP2) suppress the severe phenotype of succinic semialdehyde dehydrogenase (ssadh) mutants in Arabidopsis. PloS one 20080101
Retinopathy induced by drugs and herbal medicines. European review for medical and pharmacological sciences 20080101
Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development. BMC developmental biology 20080101
Effect of cocaine on responsiveness of alpha(1)-adrenergic receptors in rat cerebral cortex: modulation by GABA-mimetic drugs. Pharmacological reports : PR 20080101
Ocular adverse effects of Topiramate: Two case reports. Indian journal of pharmacology 20080101
Up-regulated astroglial TWIK-related acid-sensitive K+ channel-1 (TASK-1) in the hippocampus of seizure-sensitive gerbils: a target of anti-epileptic drugs. Brain research 20071214
GABAA-receptor modification in taurine transporter knockout mice causes striatal disinhibition. The Journal of physiology 20071201
The new antiepileptic drugs. Archives of disease in childhood. Education and practice edition 20071201
Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic disorders : international epilepsy journal with videotape 20071201
Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity. Dialogues in clinical neuroscience 20071201
Therapeutic options and challenges for substances of abuse. Dialogues in clinical neuroscience 20071201
Hypoxia-induced changes of seizure susceptibility in immature rats are modified by vigabatrin. Epileptic disorders : international epilepsy journal with videotape 20071201
Current role of vigabatrin in infantile spasms. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20071101
Levetiracetam monotherapy in newly diagnosed cryptogenic West syndrome. Pediatric neurology 20071101
[Vigabatrin toxic retinopathy]. Archivos de la Sociedad Espanola de Oftalmologia 20071101
Determination of vigabatrin in human plasma by means of CE with LIF detection. Electrophoresis 20071001
Treatment of infantile spasms with sodium valproate followed by benzodiazepines. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20071001
[Effects of antiepileptic drugs on mood of people with epilepsy]. Ideggyogyaszati szemle 20070930
Infantile spasms and cytomegalovirus infection: antiviral and antiepileptic treatment. Developmental medicine and child neurology 20070901
Treatment of infantile spasms with sodium valproate followed by benzodiazepines. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20070901
Neuro-ophthalmologic aspects of multiple sclerosis: Using eye movements as a clinical and experimental tool. Clinical ophthalmology (Auckland, N.Z.) 20070901
The effects of vigabatrin on spike and wave discharges in WAG/Rij rats. Epilepsy research 20070801
Contrast sensitivity is reduced in children with infantile spasms. Investigative ophthalmology & visual science 20070801
Visual field defect during therapy with valproic-acid. European journal of neurology 20070801
Treatment before seizures: new indications for antiepileptic therapy in children with tuberous sclerosis complex. Epilepsia 20070801
Antiepileptic drugs for the treatment of post-traumatic stress disorder. Current psychiatry reports 20070801
Stereoselective determination of vigabatrin enantiomers in human plasma by high performance liquid chromatography using UV detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070701
Use of the newer antiepileptic drugs in pediatric epilepsies. Current treatment options in neurology 20070701
Vigabatrin and epilepsy: lessons learned. Epilepsia 20070701
[Protective effects of vigabatrin and atropine against dimethoate induced-intoxication in mice]. Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases 20070701
Study pharmacologic of the GABAergic and glutamatergic drugs on seizures and status epilepticus induced by pilocarpine in adult Wistar rats. Neuroscience letters 20070604
Prioritizing children's medicines for research: a pharmaco-epidemiological study of antiepileptic drugs. British journal of clinical pharmacology 20070601
Central neural activity in rats with tinnitus evaluated with manganese-enhanced magnetic resonance imaging (MEMRI). Hearing research 20070601
The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. Journal of clinical psychopharmacology 20070601
Update of the medical treatment of West syndrome. Minerva pediatrica 20070601
Status gelasticus associated with levetiracetam as add-on treatment. Epileptic disorders : international epilepsy journal with videotape 20070601
Antiepileptic drugs and visual function. Pediatric neurology 20070601
Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 20070515
A novel high sensitivity HPLC assay for topiramate, using 4-chloro-7-nitrobenzofurazan as pre-column fluorescence derivatizing agent. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501
Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats. Psychopharmacology 20070501
GABAergic mechanisms in absence epilepsy: a computational model of absence epilepsy simulating spike and wave discharges after vigabatrin in WAG/Rij rats. The European journal of neuroscience 20070501
Vigabatrin improves paroxysmal dystonia in succinic semialdehyde dehydrogenase deficiency. Neurology 20070417
Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience 20070414
Use and safety profile of antiepileptic drugs in Italy. European journal of clinical pharmacology 20070401
Fetal exposure to GABA-acting antiepileptic drugs generates hippocampal and cortical dysplasias. Epilepsia 20070401
Response: images and interventions. Science & practice perspectives 20070401
Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy. Progress in neuro-psychopharmacology & biological psychiatry 20070330
Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model. Journal of the Association for Research in Otolaryngology : JARO 20070301
Depression in epilepsy: phenomenology, diagnosis and management. Epileptic disorders : international epilepsy journal with videotape 20070301
Severe relapse of epilepsy after vigabatrin withdrawal: for how long should we treat symptomatic infantile spasms? Epilepsia 20070301
[Treatment of West syndrome with vigabatrin: clinical and electroencephalographic evaluation of 13 patients]. Arquivos de neuro-psiquiatria 20070301
[Psychotropic drug-induced change of weight: a review]. Fortschritte der Neurologie-Psychiatrie 20070201
Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Epilepsy & behavior : E&B 20070201
Effect of antiepileptic drugs on spontaneous seizures in epileptic rats. Epilepsy research 20070201
[Newer antiepileptic drugs]. No to shinkei = Brain and nerve 20070201
[Newer antiepileptic drugs]. Brain and nerve = Shinkei kenkyu no shinpo 20070201
D-bifunctional protein deficiency associated with drug resistant infantile spasms. Brain & development 20070101
Quantification of cortical GABA-glutamine cycling rate using in vivo magnetic resonance signal of [2-13C]GABA derived from glia-specific substrate [2-13C]acetate. Neurochemistry international 20070101
The pharmacokinetics of vigabatrin in rat blood and cerebrospinal fluid. Seizure 20070101
Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII). Epilepsy research 20070101
Targets for antiepileptic drugs in the synapse. Medical science monitor : international medical journal of experimental and clinical research 20070101
Vigabatrin. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20070101
Ocular adverse effects associated with systemic medications : recognition and management. Drugs 20070101
Suicidality and antiepileptic drugs: is there a link? Drug safety 20070101
Inborn errors in the metabolism of glutathione. Orphanet journal of rare diseases 20070101
Neurobiology of memory and anxiety: from genes to behavior. Neural plasticity 20070101
Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug safety 20070101
[Retinal dysfunction in patients treated with vigabatrin]. Klinika oczna 20070101
[Epilepsy and Sabril]. Bulletin de la Societe belge d'ophtalmologie 20070101
Effect of NG-nitro-L-arginine on the anticonvulsant action of four second-generation antiepileptic drugs in pentetrazole-induced clonic seizures in mice. Pharmacological reports : PR 20070101
Pathogenesis and pharmacology of epilepsy in the lithium-pilocarpine model. Epilepsia 20070101
Weight issues for people with epilepsy--a review. Epilepsia 20070101
Optimizing therapy of seizures in patients with renal or hepatic dysfunction. Neurology 20061226
Optimizing therapy of seizures in women who use oral contraceptives. Neurology 20061226
Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors. Journal of medicinal chemistry 20061214
Vigabatrin-attributable visual field defects in patients with intractable partial epilepsy. Acta neurologica Taiwanica 20061201
Psychopharmacology of topiramate: from epilepsy to bipolar disorder. Neuropsychiatric disease and treatment 20061201
The co-treatments of vigabatrin and P2X receptor antagonists protect ischemic neuronal cell death in the gerbil hippocampus. Brain research 20061120
Diagnosis and treatment of neurotransmitter disorders. Current treatment options in neurology 20061101
Treatment of infantile spasms. Current treatment options in neurology 20061101
Retinal function and histopathology in rabbits treated with Topiramate. Documenta ophthalmologica. Advances in ophthalmology 20061101
European Academy of Paediatrics, Barcelona, Spain, October 7-10, 2006. Abstracts. European journal of pediatrics 20061101
Focal transient lesion in the splenium of the corpus callosum in three non-epileptic patients. Neuroradiology 20061001
The use of TDM data to assess the validity of defined daily doses of antiepileptics: a comparison between a Czech and Swedish University Hospital. Therapeutic drug monitoring 20061001
A case of infantile Alexander disease accompanied by infantile spasms diagnosed by DNA analysis. Journal of Korean medical science 20061001
The natural history of Vigabatrin-associated visual field defects in patients electing to continue their medication. Eye (London, England) 20060901
[New developments in the pharmacotherapy of cocaine dependence]. Der Nervenarzt 20060901
Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: ocular safety pilot results. Archives of ophthalmology (Chicago, Ill. : 1960) 20060901
Differences between prescribed daily doses and defined daily doses of antiepileptics--therapeutic drug monitoring as a marker of the quality of the treatment. International journal of clinical pharmacology and therapeutics 20060901
Zonisamide - a review of experience and use in partial seizures. Neuropsychiatric disease and treatment 20060901
Topiramate monotherapy in infantile spasm. Yonsei medical journal 20060831
A pharmacogenetic exploration of vigabatrin-induced visual field constriction. Epilepsy research 20060801
Gabapentin increases a tonic inhibitory conductance in hippocampal pyramidal neurons. Anesthesiology 20060801
Vigabatrin and visual field defects in pediatric epilepsy patients. Journal of Korean medical science 20060801
Drug hypersensitivity to previously tolerated phenytoin by carbamazepine-induced DRESS syndrome. Journal of Korean medical science 20060801
Enhancement of brain kynurenic acid production by anticonvulsants--novel mechanism of antiepileptic activity? European journal of pharmacology 20060717
Various GABA-mimetic drugs differently affect cocaine-evoked hyperlocomotion and sensitization. European journal of pharmacology 20060717
Clinical, cytogenetic and molecular characterization of a patient with combined succinic semialdehyde dehydrogenase deficiency and incomplete WAGR syndrome with obesity. Molecular genetics and metabolism 20060701
Autistic regression associated with seizure onset in an infant with tuberous sclerosis. Developmental medicine and child neurology 20060701
Visual field loss in young children and mentally handicapped adolescents receiving vigabatrin. Investigative ophthalmology & visual science 20060701
Time-frequency analysis of spike-wave discharges using a modified wavelet transform. Journal of neuroscience methods 20060630
[The effects of medications on the eyes]. La Revue du praticien 20060615
[Asymptomatic concentric visual field deficits and optic nerve atrophy]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20060601
Tiagabine and vigabatrin reduce the severity of NMDA-induced excitotoxicity in chick retina. Experimental brain research 20060601
Cryptogenic late-onset epileptic spasms: an overlooked syndrome of early childhood? Epilepsia 20060601
Limited P-glycoprotein mediated efflux for anti-epileptic drugs. Journal of drug targeting 20060601
Inhibition of rabbit brain 4-aminobutyrate transaminase by some taurine analogues: a kinetic analysis. Biochemical pharmacology 20060514
Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain : a journal of neurology 20060501
Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention. Yonsei medical journal 20060430
Starting and stopping mechanisms of absence epileptic seizures are revealed by hazard functions. Journal of neuroscience methods 20060415
Capillary electrophoresis enantioselective separation of vigabatrin enantiomers by precolumn derivatization with dehydroabietylisothiocyante and UV-vis detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060403
[Treatment of infantile spasms]. Ugeskrift for laeger 20060403
Current management for epilepsy in tuberous sclerosis complex. Current opinion in neurology 20060401
Evidence that GAD65 mediates increased GABA synthesis during intense neuronal activity in vivo. Journal of neurochemistry 20060401
Synthesis of functionalized pyrrolidin-2-ones and (S)-Vigabatrin from pyrrole. The Journal of organic chemistry 20060303
Glucose inhibits GABA release by pancreatic beta-cells through an increase in GABA shunt activity. American journal of physiology. Endocrinology and metabolism 20060301
New substrates and inhibitors of gamma-aminobutyric acid aminotransferase containing bioisosteres of the carboxylic acid group: design, synthesis, and biological activity. Bioorganic & medicinal chemistry 20060301
Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer. Investigative ophthalmology & visual science 20060301
Aicardi syndrome: a report of five Indian cases. Neurology India 20060301
Vigabatrin transport across the human intestinal epithelial (Caco-2) brush-border membrane is via the H+ -coupled amino-acid transporter hPAT1. British journal of pharmacology 20060201
Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose. Epilepsia 20060201
Reduced calcium binding protein immunoreactivity induced by electroconvulsive shock indicates neuronal hyperactivity, not neuronal death or deactivation. Neuroscience 20060101
Interactions between antiepileptic and antipsychotic drugs. Drug safety 20060101
Demonstration of extensive GABA synthesis in the small population of GAD positive neurons in cerebellar cultures by the use of pharmacological tools. Neurochemistry international 20060101
Acute regulation of steady-state GABA levels following GABA-transaminase inhibition in rat cerebral cortex. Neurochemistry international 20060101
Vigabatrin caused rapidly progressive deterioration in two cases with early myoclonic encephalopathy associated with nonketotic hyperglycinemia. Journal of child neurology 20060101
Vigabatrin in pediatric patients with refractory epilepsy. The Turkish journal of pediatrics 20060101
Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age. Clinical pharmacokinetics 20060101
Retinal function in rabbits does not improve 4-5 months after terminating treatment with vigabatrin. Documenta ophthalmologica. Advances in ophthalmology 20060101
A plausible explanation for superiority of adreno-cortico-trophic hormone (ACTH) over oral corticosteroids in management of infantile spasms (West syndrome). Medical hypotheses 20060101
Glial modulation of GABAergic and glutamat ergic neurotransmission. Current topics in medicinal chemistry 20060101
Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Clinical pharmacokinetics 20060101
Pragmatic difficulties in children with autism associated with childhood epilepsy. Pediatric rehabilitation 20060101
Prolonged nicotine exposure does not alter GABA(B) receptor-mediated regulation of brain reward function. Neuropharmacology 20051201
[Infantile spasms as the first manifestation of propionic acidemia]. Anales de pediatria (Barcelona, Spain : 2003) 20051201
Pharmacokinetic variability of new antiepileptic drugs at different ages. Therapeutic drug monitoring 20051201
Valproic acid reduces enhanced vesicular glutamate transporter immunoreactivities in the dentate gyrus of the seizure prone gerbil. Neuropharmacology 20051101
The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. The Lancet. Neurology 20051101
Visual defects associated with vigabatrin: a study of epileptic argentine patients. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20051101
Induction of endogenous pathways by antiepileptics and clinical implications. Fundamental & clinical pharmacology 20051001
Differential effects of vigabatrin and zonisamide on the neuropeptide Y system in the hippocampus of seizure prone gerbil. Neuropeptides 20051001
Visual function in epilepsy patients treated with initial valproate monotherapy. Seizure 20050901
Effect of neurosteroids on the retinal gabaergic system and electroretinographic activity in the golden hamster. Journal of neurochemistry 20050901
Preclinical profiling and safety studies of ABT-769: a compound with potential for broad-spectrum antiepileptic activity. Epilepsia 20050901
Towards a synthesis of vigabatrin using glycal chemistry. Molecules (Basel, Switzerland) 20050831
[Infantile spasms]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20050825
[Infantile spasms]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20050811
Application of capillary zone electrophoresis with indirect UV detection to the determination of a model drug, vigabatrin, in dosage forms. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20050803
Ocular complications of neurological therapy. European journal of neurology 20050701
Vigabatrin toxicity in children. Ophthalmology 20050701
Ophthalmologic and neurologic findings in two children exposed to vigabatrin in utero. Epilepsy research 20050601
Vigabatrin in low doses selectively suppresses the clonic component of audiogenically kindled seizures in rats. Epilepsia 20050601
Maternal exposure to the antiepileptic drug vigabatrin affects postnatal development in the rat. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20050601
[Efficacy and tolerability of vigabatrin in West syndrome]. Arquivos de neuro-psiquiatria 20050601
Cross Hypersensitivity Syndrome between Phenytoin and Carbamazepine. Pharmacy world & science : PWS 20050601
[Electrophysiological monitoring of epileptic patients treated with Vigabatrin]. Journal francais d'ophtalmologie 20050601
Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050501
Beneficial interaction between vigabatrin and valproate against seizures induced by pentylenetetrazole in mice. Pharmacological research 20050501
GABAergic modulation of the expression of genes involved in GABA synaptic transmission and stress in the hypothalamus and telencephalon of the female goldfish (Carassius auratus). Journal of neuroendocrinology 20050501
Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder. Journal of psychiatry & neuroscience : JPN 20050501
Evaluation of health status in epilepsy using the EQ-5D questionnaire: a prospective, observational, 6-month study of adjunctive therapy with anti-epileptic drugs. Current medical research and opinion 20050501
Quantitative determination of vigabatrin and gabapentin in human serum by gas chromatography-mass spectrometry. Clinica chimica acta; international journal of clinical chemistry 20050401
The safety and effectiveness of newer antiepileptics: a comparative postmarketing cohort study. Journal of clinical pharmacology 20050401
The latest on infantile spasms. Current opinion in neurology 20050401
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health technology assessment (Winchester, England) 20050401
Novel anticonvulsants in the treatment of alcoholism. Expert opinion on investigational drugs 20050401
Nitric oxide stimulates gamma-aminobutyric acid release and inhibits glycine release in retina. The Journal of comparative neurology 20050314
Profile of West syndrome in North Indian children. Brain & development 20050301
The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood. Seizure 20050301
[Linear nevus sebaceous syndrome with hemimegalencephaly diagnosed in child in neonatal period]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20050301
Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction. Synapse (New York, N.Y.) 20050201
Elevated endogenous GABA level correlates with decreased fMRI signals in the rat brain during acute inhibition of GABA transaminase. Journal of neuroscience research 20050201
Catecholamine depletion modulates serum LH levels, GAD67 mRNA, and GABA synthesis in the goldfish. General and comparative endocrinology 20050201
Reduced visual function associated with infantile spasms in children on vigabatrin therapy. Investigative ophthalmology & visual science 20050201
Analysis of antiepileptic drugs in biological fluids by means of electrokinetic chromatography. Electrophoresis 20050201
The relationship between hippocampal EEG theta activity and locomotor behaviour in freely moving rats: effects of vigabatrin. Brain research bulletin 20050130
GABA shunt deficiencies and accumulation of reactive oxygen intermediates: insight from Arabidopsis mutants. FEBS letters 20050117
The natural history of Vigabatrin associated visual field defects in patients electing to continue their medication. Eye (London, England) 20050101
Mechanisms of action of antiepileptic drugs. Current topics in medicinal chemistry 20050101
Antiepileptic action induced by a combination of vigabatrin and tiagabine. Neuroscience 20050101
[Treatment of West syndrome]. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20050101
[Electroencephalography in status epilepticus in sleep (ESES) in various clinical pictures]. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti 20050101
Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials. Epilepsy research 20050101
Effect of maternal administration of vigabatrin during late gestation on fetoplacental amino acid profile in the mouse. Reproductive toxicology (Elmsford, N.Y.) 20050101
Antiepileptic drugs in mood-disordered patients. Epilepsia 20050101
Ion channels and epilepsy. Current pharmaceutical design 20050101
Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents. Roczniki Akademii Medycznej w Bialymstoku (1995) 20050101
New antiepileptic drugs--an overview. Roczniki Akademii Medycznej w Bialymstoku (1995) 20050101
A comparative study of vigabatrin vs. carbamazepine in monotherapy of newly diagnosed partial seizures in children. Pharmacological reports : PR 20050101
[The efficacy of topiramate (topamax) in the treatment of resistant epilepsy in children]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101
The effects of vigabatrin on rat liver antioxidant status. Drug metabolism and drug interactions 20050101
Management of Landau-Kleffner syndrome. Paediatric drugs 20050101
Role of opioidergic mechanisms and GABA uptake inhibition in the heroin-induced discriminative stimulus effects in rats. Pharmacological reports : PR 20050101
Comprehensive analysis of pyrimidine metabolism in 450 children with unspecific neurological symptoms using high-pressure liquid chromatography-electrospray ionization tandem mass spectrometry. Journal of inherited metabolic disease 20050101
[Epilepsy with polymorphic seizures in hospitalized children]. Przeglad lekarski 20050101
[The function of eye and vision system in children and youth treated with vigabatrin--our own experiences]. Klinika oczna 20050101
[Current pharmacotherapy of epilepsy in adults]. Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg 20050101
Gamma-vinyl GABA (vigabatrin) blocks the expression of toluene-induced conditioned place preference (CPP). Synapse (New York, N.Y.) 20041201
Effect of Vigabatrin on motor responses to transcranial magnetic stimulation: an effective tool to investigate in vivo GABAergic cortical inhibition in humans. Brain research 20041126
Early treatment of Aicardi syndrome with vigabatrin can improve outcome. Neurology 20041109
Conformationally-restricted vigabatrin analogs as irreversible and reversible inhibitors of gamma-aminobutyric acid aminotransferase. Bioorganic & medicinal chemistry 20041101
The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet (London, England) 20041101
Simultaneous high-performance liquid chromatographic analysis of pregabalin, gabapentin and vigabatrin in human serum by precolumn derivatization with o-phtaldialdehyde and fluorescence detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041025
Visual field constriction associated with vigabatrin: retinal nerve fiber layer photographic correlation. Journal of neurology, neurosurgery, and psychiatry 20041001
Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. The Lancet. Neurology 20041001
A new strategy for in vivo spectral editing. Application to GABA editing using selective homonuclear polarization transfer spectroscopy. Journal of magnetic resonance (San Diego, Calif. : 1997) 20041001
Characteristic retinal atrophy with secondary 'inverse' optic atrophy identifies vigabatrin toxicity in children. Ophthalmology 20041001
Anticonvulsant drugs in primary headaches prophylaxis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20041001
Increased GAD67 mRNA levels are correlated with in vivo GABA synthesis in the MPTP-treated catecholamine-depleted goldfish brain. Brain research. Molecular brain research 20040928
Alpha 5 subunit-containing GABAA receptors affect the dynamic range of mouse hippocampal kainate-induced gamma frequency oscillations in vitro. The Journal of physiology 20040915
The effect of GABA and the GABA-uptake-blocker NO-711 on the b-wave of the ERG and the responses of horizontal cells to light. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20040901
Acute vigabatrin retinotoxicity in albino rats depends on light but not GABA. Epilepsia 20040901
Vigabatrin and tiagabine might have antipanic properties. Journal of psychopharmacology (Oxford, England) 20040901
Drug selection for the newly diagnosed patient: when is a new generation antiepileptic drug indicated? Journal of neurology 20040901
Managing epilepsy in tuberous sclerosis complex. Journal of child neurology 20040901
Crystal structures of unbound and aminooxyacetate-bound Escherichia coli gamma-aminobutyrate aminotransferase. Biochemistry 20040831
Altered GABAB receptor immunoreactivity in the gerbil hippocampus induced by baclofen and phaclofen, not seizure activity. Neuroscience research 20040801
Synthesis of cyclopropane isosteres of the antiepilepsy drug vigabatrin and evaluation of their inhibition of GABA aminotransferase. Journal of enzyme inhibition and medicinal chemistry 20040801
The interaction between vigabatrin and diazepam on the electroencephalogram during active behaviour in rats: an isobolic analysis. European journal of pharmacology 20040714
Simultaneous determination of vigabatrin and amino acid neurotransmitters in brain microdialysates by capillary electrophoresis with laser-induced fluorescence detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040705
Altered Na+-K+ ATPase immunoreactivity within GABAergic neurons in the gerbil hippocampal complex induced by spontaneous seizure and vigabatrin treatment. Neurochemistry international 20040701
Development of vigabatrin-induced lesions in the rat brain studied by magnetic resonance imaging, histology, and immunocytochemistry. Synapse (New York, N.Y.) 20040701
The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia 20040701
Subacute sclerosing panencephalitis: a case with fulminant course after ACTH. Pediatric neurology 20040701
Are vigabatrin-associated visual field constrictions asymptomatic? Journal of neurology 20040701
Transcranial magnetic stimulation: applications for neuropsychopharmacology. Journal of psychopharmacology (Oxford, England) 20040601
Spectrum of epilepsy in tuberous sclerosis. Neurology India 20040601
[Treatment protocol for long-term anti-epilepsy drugs in adults with refractory partial epilepsy]. Revue neurologique 20040601
The effect of Vigabatrin, Lamotrigine and Gabapentin on the fertility, weights, sex hormones and biochemical profiles of male rats. Neuro endocrinology letters 20040601
Infantile spasms: therapy and outcome. Journal of child neurology 20040601
New pharmacotherapies for pediatric seizures. Pediatric annals 20040601
Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 20040525
Design, synthesis and anticonvulsive activity of analogs of gamma-vinyl GABA. Farmaco (Societa chimica italiana : 1989) 20040501
Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats. Annals of neurology 20040501
Perinatal exposure to GABA-transaminase inhibitor impaired psychomotor function in the developing and adult mouse. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20040501
Drugs and the retina. Expert opinion on drug safety 20040501
Combined treatment with vigabatrin and topiramate in West syndrome. Journal of child neurology 20040501
Brain GABA editing by localized in vivo (1)H magnetic resonance spectroscopy. NMR in biomedicine 20040401
Scotopic threshold response changes after vigabatrin therapy in a child without visual field defects: a new electroretinographic marker of early damage? Neurobiology of disease 20040401
Adverse effects of new antiepileptic drugs. Drugs of today (Barcelona, Spain : 1998) 20040401
Determination of vigabatrin in human plasma and urine by high-performance liquid chromatography with UV-Vis detection. Journal of chromatography. A 20040326
Biphasic action of vigabatrin on cortical epileptic after-discharges in rats. Naunyn-Schmiedeberg's archives of pharmacology 20040301
Interaction between anticonvulsants and human placental carnitine transporter. Epilepsia 20040301
The effect of antiepileptic drugs on visual performance. Seizure 20040301
Alterations in electroretinograms and retinal morphology in rabbits treated with vigabatrin. Documenta ophthalmologica. Advances in ophthalmology 20040301
Vigabatrin inhibits pyridoxine-5'-phosphate oxidase, not pyridoxal kinase in the hippocampus of seizure prone gerbils. Neurochemistry international 20040201
Vigabatrin-induced modification of Ki-67 expression in gingival epithelium: immunohistochemical study of a short series. Journal of periodontal research 20040201
Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. Stroke 20040201
Vigabatrin-associated loss of vision: rarebit perimetry illuminates the dose-damage relationship. Acta ophthalmologica Scandinavica 20040201
Structures of gamma-aminobutyric acid (GABA) aminotransferase, a pyridoxal 5'-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with gamma-ethynyl-GABA and with the antiepilepsy drug vigabatrin. The Journal of biological chemistry 20040102
Behavioural effects of the newer antiepileptic drugs: an update. Expert opinion on drug safety 20040101
Treatment of partial seizures in childhood : an overview. CNS drugs 20040101
New antiepileptic agents. Pediatric dentistry 20040101
The central piriform cortex: anatomical connections and anticonvulsant effect of GABA elevation in the kindling model. Neuroscience 20040101
Agents in development for the management of cocaine abuse. Drugs 20040101
Role of the GABA transporter in epilepsy. Advances in experimental medicine and biology 20040101
Pharmacologic treatment of the catastrophic epilepsies. Epilepsia 20040101
Succinic semialdehyde dehydrogenase deficiency (SSADH) (4-hydroxybutyric aciduria, gamma-hydroxybutyric aciduria). European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20040101
The time-frequency structure of the spike-wave discharges in genetic absence epilepsy. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections 20040101
Bilateral microinjections of vigabatrin in the central piriform cortex retard amygdala kindling in rats. Neuroscience 20040101
Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy research 20040101
Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clinical chemistry and laboratory medicine 20040101
[Neuroprotective activity of antiepileptic drugs]. Przeglad lekarski 20040101
Peripheral retinal dysfunction in patients taking vigabatrin. Neurology 20031223
Design, synthesis, and biological activity of a difluoro-substituted, conformationally rigid vigabatrin analogue as a potent gamma-aminobutyric acid aminotransferase inhibitor. Journal of medicinal chemistry 20031204
Positron emission tomography studies of potential mechanisms underlying phencyclidine-induced alterations in striatal dopamine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031201
Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA. Synapse (New York, N.Y.) 20031201
[Vigabatrin in the treatment of epilepsy in patients with West syndrome and tuberous sclerosis]. Arquivos de neuro-psiquiatria 20031201
Monitoring of 4-hydroxybutyric acid levels in body fluids during vigabatrin treatment in succinic semialdehyde dehydrogenase deficiency. Annals of neurology 20031101
Infantile spasms. Expert opinion on pharmacotherapy 20031101
Effects of antiepileptic drugs on refractory seizures in the intact immature corticohippocampal formation in vitro. Epilepsia 20031101
Examining visual field defects in the paediatric population exposed to vigabatrin. Documenta ophthalmologica. Advances in ophthalmology 20031101
Longitudinal changes in photopic OPs occurring with vigabatrin treatment. Documenta ophthalmologica. Advances in ophthalmology 20031101
Changes in the electroretinogram resulting from discontinuation of vigabatrin in children. Documenta ophthalmologica. Advances in ophthalmology 20031101
Sensorineural hearing loss: a reversible effect of vigabatrin. Neurology 20031014
Boosting GABA improves impaired auditory temporal resolution in the gerbil. Neuroreport 20031006
Vigabatrin: longterm follow-up of electrophysiology and visual field examinations. Acta ophthalmologica Scandinavica 20031001
Characterization of vigabatrin-associated optic atrophy. Acta ophthalmologica Scandinavica 20031001
Design, synthesis and anticonvulsive activities of potential prodrugs linked by two-carbon chain. Archives of pharmacal research 20031001
Visual field defects in pediatric patients on vigabatrin monotherapy. Documenta ophthalmologica. Advances in ophthalmology 20030901
Determination of vigabatrin by capillary electrophoresis with laser-induced fluorescence detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030825
P2X2 and P2X4 receptor expression is regulated by a GABA(A) receptor-mediated mechanism in the gerbil hippocampus. Brain research. Molecular brain research 20030819
GABA transporters and GABA-transaminase as drug targets. Current drug targets. CNS and neurological disorders 20030801
Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study. Therapeutic drug monitoring 20030801
Treatment of infantile spasms: the ideal and the mundane. Epilepsia 20030801
Short-term nonhormonal and nonsteroid treatment in West syndrome. Epilepsia 20030801
The importance of being seizure free: topiramate and psychopathology in epilepsy. Epilepsy & behavior : E&B 20030801
Kinetic studies on the inhibition of GABA-T by gamma-vinyl GABA and taurine. Journal of enzyme inhibition and medicinal chemistry 20030801
Analgesia and hyperalgesia from GABA-mediated modulation of the cerebral cortex. Nature 20030717
Sub-chronic low dose gamma-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine. Psychopharmacology 20030701
Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations. Seizure 20030701
Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina. Epilepsia 20030701
[Significance of GABAA receptors for the pathophysiology and therapy of panic disorders]. Der Nervenarzt 20030701
Successful pregnancy in a patient with hyperoxaluria and combined liver and renal transplant. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20030701
Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology 20030610
Effect of vigabatrin on contractile response to arachidonic acid and prostaglandins in smooth muscle preparations and platelet aggregation in experimental laboratory animals. Pharmacological research 20030601
Therapeutic drug monitoring of the newer antiepileptic drugs. Therapeutic drug monitoring 20030601
Simultaneous isocratic HPLC determination of vigabatrin and gabapentin in human plasma by dansyl derivatization. Therapeutic drug monitoring 20030601
Retinal function abnormalities in patients treated with vigabatrin. Archives of ophthalmology (Chicago, Ill. : 1960) 20030601
Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. The Lancet. Neurology 20030601
GABA-ergic drugs: exit stage left, enter stage right. Journal of psychopharmacology (Oxford, England) 20030601
Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen. Neuropediatrics 20030601
Infantile spasms with basal ganglia MRI hypersignal may reveal mitochondrial disorder due to T8993G MT DNA mutation. Neuropediatrics 20030601
The evidence for GABAB receptor-mediated regulation of acid-base balance: involvement of Na+/H+ exchanger and Na+/HCO3- cotransporter. Brain research. Molecular brain research 20030526
Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030501
[Vigabatrin-associated bilateral simple optic nerve atrophy with visual field constriction. A case report and a survey of the literature]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20030501
Experimental anxiety and antiepileptics: the effects of valproate and vigabatrin in the mirrored chamber test. Methods and findings in experimental and clinical pharmacology 20030501
Antiepileptic drugs and apoptosis in the developing brain. Annals of the New York Academy of Sciences 20030501
The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come? Epileptic disorders : international epilepsy journal with videotape 20030501
Effect of vigabatrin on glutamate dehydrogenase in the hippocampus of seizure prone gerbils. Neuroscience letters 20030410
Vigabatrin induces tonic inhibition via GABA transporter reversal without increasing vesicular GABA release. Journal of neurophysiology 20030401
Failure of ischemic neuroprotection by potentiators of gamma-aminobutyric acid. Clinical medicine & research 20030401
[New epileptic treatments. Current modalities and their utilization]. Presse medicale (Paris, France : 1983) 20030308
The effects of vigabatrin on type II spike wave discharges in rats. Neuroscience letters 20030306
[Vigabatrin and visual field defects. A Danish material with evaluation of different screening methods]. Ugeskrift for laeger 20030303
Vigabatrin, tiagabine, and visual fields. Journal of neurology, neurosurgery, and psychiatry 20030301
A controlled study comparing visual function in patients treated with vigabatrin and tiagabine. Journal of neurology, neurosurgery, and psychiatry 20030301
Responsiveness of the quality of life in epilepsy inventory (QOLIE-89) in an antiepileptic drug trial. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20030301
Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms. Journal of child neurology 20030301
Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine. Epileptic disorders : international epilepsy journal with videotape 20030301
Protein 4.1N is required for translocation of inositol 1,4,5-trisphosphate receptor type 1 to the basolateral membrane domain in polarized Madin-Darby canine kidney cells. The Journal of biological chemistry 20030207
Immunohistochemistry as a tool for topographical semi-quantification of neurotransmitters in the brain. Brain research. Brain research protocols 20030201
Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials. Epilepsy research 20030201
In vivo monitoring of rat brain metabolites during vigabatrin treatment using localized 2D-COSY. NMR in biomedicine 20030201
Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate. Neurochemical research 20030201
Vigabatrin-associated visual field constriction in a longitudinal series. Reversibility suggested after drug withdrawal. Acta ophthalmologica Scandinavica 20030201
Changed vesicular GABA transporter immunoreactivity in the gerbil hippocampus following spontaneous seizure and vigabatrin administration. Neuroscience letters 20030102
Epilepsy patients treated with vigabatrin exhibit reduced ocular blood flow. The British journal of ophthalmology 20030101
The absorption of gabapentin following high dose escalation. Seizure 20030101
Effects of vigabatrin on brain GABA+/Cr signals in focus-distant and focus-near brain regions monitored by 1H-NMR spectroscopy. European journal of neurology 20030101
Anti-epileptic drugs-induced de novo absence seizures. Brain & development 20030101
Interlaboratory variability in the quantification of new generation antiepileptic drugs based on external quality assessment data. Epilepsia 20030101
Selection criteria for the clinical use of the newer antiepileptic drugs. CNS drugs 20030101
Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency. Annals of neurology 20030101
Treatment of infantile spasms. The Cochrane database of systematic reviews 20030101
Influence of vigabatrin, a novel antiepileptic drug, on the anticonvulsant activity of conventional antiepileptics in pentetrazole-induced seizures in mice. Polish journal of pharmacology 20030101
Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms. Paediatric drugs 20030101
Anti-spasticity agents for multiple sclerosis. The Cochrane database of systematic reviews 20030101
[Stiff man syndrome successfully controlled with glucocorticoids and GABA-ergic drug administration: case report]. Neurologia i neurochirurgia polska 20030101
[Changes in visual field of a child treatment with vigabatrin for 2 years]. Klinika oczna 20030101
[Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy]. Klinika oczna 20030101
The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacology bulletin 20030101
Gamma-vinyl GABA, an irreversible inhibitor of GABA transaminase, alters the acquisition and expression of cocaine-induced sensitization in male rats. Synapse (New York, N.Y.) 20021215
Modulation of the in vivo effects of gabapentin by vigabatrin and SKF89976A. Epilepsy research 20021201
Pre- rather than co-application of vigabatrin increases the efficacy of tiagabine in hippocampal slices. Epilepsia 20021201
Vigabatrin and visual field disorders. Prescrire international 20021201
Effect of vigabatrin on the pharmacokinetics of carbamazepine. Journal of clinical pharmacy and therapeutics 20021201
[Constriction of the visual field by vigabatrin]. Anales de medicina interna (Madrid, Spain : 1984) 20021201
Patients treated with vigabatrin exhibit central visual function loss. Epilepsia 20021101
Detection of visual field defects in patients after anterior temporal lobectomy for mesial temporal sclerosis-establishing eligibility to drive. Eye (London, England) 20021101
Successful treatment of Ohtahara syndrome with chloral hydrate. Pediatric neurology 20021101
The stiff-person syndrome. Case report. Minerva anestesiologica 20021101
The effects of GABA and vigabatrin on horizontal cell responses to light and the effect of vigabatrin on the electroretinogram. Documenta ophthalmologica. Advances in ophthalmology 20021101
Antiepileptic drugs in schizophrenia: a review. European psychiatry : the journal of the Association of European Psychiatrists 20021101
New antiepileptic drug therapies. Neurologic clinics 20021101
GABA X2 multiplet measured pre- and post-administration of vigabatrin in human brain. Magnetic resonance in medicine 20021001
Driving after epilepsy surgery: effects of visual field defects and epilepsy control. British journal of neurosurgery 20021001
Newer GABAergic agents for pharmacotherapy of infantile spasms. Drugs of today (Barcelona, Spain : 1998) 20021001
Inactivation and inhibition of gamma-aminobutyric acid aminotransferase by conformationally restricted vigabatrin analogues. Journal of medicinal chemistry 20020926
New antiepileptic drugs in childhood. Panminerva medica 20020901
The legacy of vigabatrin in a regional epilepsy clinic. Journal of neurology, neurosurgery, and psychiatry 20020901
Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal. Eye (London, England) 20020901
Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). Epilepsy research 20020901
Characteristics of epilepsy in focal cortical dysplasia in infancy. Epilepsy research 20020901
Low-dose lamotrigine in West syndrome. Epilepsy research 20020901
Neurotoxic effects of GABA-transaminase inhibitors in the treatment of epilepsy: ocular perfusion and visual performance. Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) 20020901
[Monitoring serum levels of new antiepileptics]. Revista de neurologia 20020901
Atypical benign partial epilepsy of childhood (pseudo-Lennox syndrome): report of two brothers. Neurology India 20020901
Vigabatrin for infantile spasms. Pediatric neurology 20020901
Randomized trial of vigabatrin in patients with infantile spasms. Neurology 20020827
Tangent screens are still useful in the assessment of vigabatrin induced visual field defects. The British journal of ophthalmology 20020801
The effect on vision of associated treatments in patients taking vigabatrin: carbamazepine versus valproate. Epilepsia 20020801
Is there an association between maternal carbamazepine use during pregnancy and eye malformations in the child? Epilepsia 20020801
Is visual field constriction in epilepsy patients treated with vigabatrin reversible? Journal of neurology 20020801
Effects of vigabatrin on epileptiform abnormal discharges in hippocampal CA3 neurons of spontaneously epileptic rats (SER). Epilepsy research 20020801
[Antiepileptics]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20020801
Vigabatrin therapy in infantile spasms. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20020801
Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria). The Journal of pharmacology and experimental therapeutics 20020701
Visual field constriction in 91 Finnish children treated with vigabatrin. Epilepsia 20020701
Spectrofluorimetric and spectrophotometric methods for the determination of vigabatrin in tablets. Journal of pharmaceutical and biomedical analysis 20020620
Increased GABA neurotransmission via administration of gamma-vinyl GABA decreased nicotine self-administration in the rat. Synapse (New York, N.Y.) 20020615
Effects of antiepileptic drugs on visual function, with special reference to Vigabatrin. Acta ophthalmologica Scandinavica 20020601
[New antiepileptic drugs: new therapeutic options]. Revue neurologique 20020501
Seizure reduction and quality of life improvements in people with epilepsy. Epilepsia 20020501
[Stiff limb syndrome associated with Hashimoto's encephalopathy: improvement after corticotherapy]. Revue neurologique 20020501
Gabapentin and vigabatrin increase GABA in the human neocortical slice. Epilepsy research 20020501
Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated children. Neurology 20020423
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. The Journal of biological chemistry 20020419
Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study. Journal of neurology 20020401
[Visual field defect in a patient given sodium valporate then carbamazepine: possible effect of aminotransferase inhibition]. Revue neurologique 20020401
The 'number needed to treat' with levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs). Seizure 20020401
West syndrome and other infantile epileptic encephalopathies--Indian hospital experience. Brain & development 20020301
[Visual field disturbances in epileptic patients treated with vigabatrin (sevril)]. Harefuah 20020301
The Hospital for Sick Children, Toronto, Longitudinal ERG study of children on vigabatrin. Documenta ophthalmologica. Advances in ophthalmology 20020301
Visual field constriction and electrophysiological changes associated with vigabatrin. Documenta ophthalmologica. Advances in ophthalmology 20020301
Vigabatrin and retinal changes. Documenta ophthalmologica. Advances in ophthalmology 20020301
Visual field and electrophysiological abnormalities due to vigabatrin. Documenta ophthalmologica. Advances in ophthalmology 20020301
Electro-ophthalmological recovery after withdrawal from vigabatrin. Documenta ophthalmologica. Advances in ophthalmology 20020301
The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms. Documenta ophthalmologica. Advances in ophthalmology 20020301
Vigabatrin; its effect on the electrophysiology of vision. Documenta ophthalmologica. Advances in ophthalmology 20020301
[Adverse reactions and interactions of antiepileptic drugs in epileptic women]. Revista de neurologia 20020301
Design of a conformationally restricted analogue of the antiepilepsy drug Vigabatrin that directs its mechanism of inactivation of gamma-aminobutyric acid aminotransferase. Journal of the American Chemical Society 20020227
Marketed new antiepileptic drugs: are they better than old-generation agents? Therapeutic drug monitoring 20020201
New antiepileptic drugs: review on drug interactions. Therapeutic drug monitoring 20020201
The promise of new antiepileptic drugs. British journal of clinical pharmacology 20020201
The effect of water temperature on the GABAergic and reproductive systems in female and male goldfish (Carassius auratus). General and comparative endocrinology 20020201
Visual field assessment and the Austroads driving standard. Clinical & experimental ophthalmology 20020201
Epidemiologic features of infantile spasms in Slovenia. Epilepsia 20020201
The costs of epilepsy in Italy: a prospective cost-of-illness study in referral patients with disease of different severity. Epilepsy research 20020201
Catalytic asymmetric intramolecular aminopalladation: enantioselective synthesis of vinyl-substituted 2-oxazolidinones, 2-imidazolidinones, and 2-pyrrolidinones. Journal of the American Chemical Society 20020109
Spectrofluorimetric determination of vigabatrin and gabapentin in urine and dosage forms through derivatization with fluorescamine. Journal of pharmaceutical and biomedical analysis 20020101
Pd asymmetric allylic alkylation (AAA). A powerful synthetic tool. Chemical & pharmaceutical bulletin 20020101
Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: a comparative review of newer versus older agents. Drugs 20020101
Interactions between antiepileptic drugs and hormonal contraception. CNS drugs 20020101
Medical treatment of patients with infantile spasms. Clinical neuropharmacology 20020101
Drug therapy for West's syndrome. Advances in experimental medicine and biology 20020101
Treatment of infantile spasms: an evidence-based approach. International review of neurobiology 20020101
Treatment of infantile spasms. The Cochrane database of systematic reviews 20020101
Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clinical pharmacokinetics 20020101
Teratogenic potential of the newer antiepileptic drugs: what is known and how should this influence prescribing? CNS drugs 20020101
[New antiepileptic drugs in pregnancy: outcome of 12 exposed pregnancies]. Therapie 20020101
Does vigabatrin possess an anticonvulsant action against pentylenetetrazol-induced seizures in developing rats? Physiological research 20020101
Adverse drug reaction update. Adverse drug reactions and toxicological reviews 20020101
[Depression in epilepsy: symptom or syndrome?]. La Clinica terapeutica 20020101
Anticonvulsant drug hypersensitivity. Journal of investigational allergology & clinical immunology 20020101
Vigabatrin associated retinal dysfunction in children with epilepsy. Archives of disease in childhood 20011201
Vigabatrin. Developmental medicine and child neurology 20011201
Clinical pharmacology and therapeutic use of the new antiepileptic drugs. Fundamental & clinical pharmacology 20011201
Infantile spasms in Down syndrome: good response to a short course of vigabatrin. Epilepsia 20011201
[Study of visual field and vigabatrin treatment in children]. Journal francais d'ophtalmologie 20011201
No reversion in vigabatrin-associated visual field defects. Neurology 20011127
Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy research 20011101
Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011101
Gamma vinyl-GABA differentially modulates NMDA antagonist-induced increases in mesocortical versus mesolimbic DA transmission. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011101
What is West syndrome? Brain & development 20011101
Infantile spasms in tuberous sclerosis complex. Brain & development 20011101
National survey on West syndrome in Korea. Brain & development 20011101
National survey of West syndrome in Taiwan. Brain & development 20011101
West syndrome: a university hospital based study from Oman. Brain & development 20011101
West syndrome and other infantile epileptic encephalopathies--Indian hospital experience. Brain & development 20011101
West syndrome in Thailand: a hospital-based survey. Brain & development 20011101
West syndrome--The University of Hong Kong experience (1970-2000). Brain & development 20011101
The treatment of West syndrome: a Cochrane review of the literature to December 2000. Brain & development 20011101
ACTH therapy of West syndrome: Finnish views. Brain & development 20011101
Vigabatrin for tuberous sclerosis complex. Brain & development 20011101
Vigabatrin directed against kindled seizures following cortical insult: impact on epileptogenesis and somatosensory recovery. Journal of neurotrauma 20011101
Pregnancy registries in epilepsy. Epilepsia 20011101
Randomized trial of vigabatrin in patients with infantile spasms. Neurology 20011023
Single systemic dose of vigabatrin induces early proconvulsant and later anticonvulsant effect in rats. Neuroscience letters 20011012
Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase. Nature genetics 20011001
Anxiolytic effects of vigabatrin in panic disorder. Journal of clinical psychopharmacology 20011001
Infantile spasms: diagnosis and assessment of treatment response by video-EEG. Developmental medicine and child neurology 20011001
Rapid development of visual field defects associated with vigabatrin therapy. Eye (London, England) 20011001
Prolonged vigabatrin treatment modifies developmental changes of GABA(A)-receptor binding in young children with epilepsy. Epilepsia 20011001
A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy. Epilepsia 20011001
GABA and the ornithine delta-aminotransferase gene in vigabatrin-associated visual field defects. Seizure 20011001
Reversed visual field constrictions in children after vigabatrin withdrawal--true retinal recovery or improved test performance only? Seizure 20011001
Visual fields and tiagabine: a quandary. Seizure 20011001
Quantitative analysis of active compounds in pharmaceutical preparations by use of attenuated total-reflection Fourier transform mid-infrared spectrophotometry and the internal standard method. Fresenius' journal of analytical chemistry 20011001
Decrease in GABA synthesis rate in rat cortex following GABA-transaminase inhibition correlates with the decrease in GAD(67) protein. Brain research 20010928
Determination of vigabatrin in human plasma and urine by high-performance liquid chromatography with fluorescence detection. Journal of chromatography. B, Biomedical sciences and applications 20010905
Gamma-vinyl GABA (GVG) blocks expression of the conditioned place preference response to heroin in rats. Synapse (New York, N.Y.) 20010901
Plasticity of rat central inhibitory synapses through GABA metabolism. The Journal of physiology 20010901
Concentric visual field restriction under vigabatrin therapy: extent depends on the duration of drug intake. Seizure 20010901
Effects of radiofrequency exposure on the GABAergic system in the rat cerebellum: clues from semi-quantitative immunohistochemistry. Brain research 20010831
Vigabatrin effect on inner retinal function. Ophthalmology 20010801
Paradoxical reduction of synaptic inhibition by vigabatrin. Journal of neurophysiology 20010801
Newer antiepileptic drugs: advantages and disadvantages. Brain & development 20010801
Is hyperprolinemia type I actually a benign trait? Report of a case with severe neurologic involvement and vigabatrin intolerance. Journal of child neurology 20010801
Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina. Neurology 20010724
Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: How valid is the GABAergic hypothesis? Journal of neurology, neurosurgery, and psychiatry 20010701
Influence of pyridoxal 5'-phosphate alone and in combination with vigabatrin on brain GABA measured by 1H-NMR-spectroscopy. Brain research bulletin 20010701
Visual field loss associated with vigabatrin: pathological correlations. Journal of neurology, neurosurgery, and psychiatry 20010601
[Reversible phenytoin-induced extrapontine myelinolysis]. Der Nervenarzt 20010601
Gamma-vinyl GABA reduces paired pulse inhibition in the rat dentate gyrus in vivo and in vitro. Epilepsy research 20010501
Vigabatrin visual toxicity: evolution and dose dependence. Epilepsia 20010501
[Therapeutic strategy in severe encephalopathies]. Revista de neurologia 20010501
[Vigabatrin-induced cytolytic hepatitis]. Gastroenterologie clinique et biologique 20010501
GABA transaminase inhibition induces spontaneous and enhances depolarization-evoked GABA efflux via reversal of the GABA transporter. The Journal of neuroscience : the official journal of the Society for Neuroscience 20010415
The value of electrophysiology results in patients with epilepsy and vigabatrin associated visual field loss. Acta ophthalmologica Scandinavica 20010401
Visual function is stable in patients who continue long-term vigabatrin therapy: implications for clinical decision making. Epilepsia 20010401
GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine. European journal of pharmacology 20010302
Development of a stable-isotope dilution assay for gamma-aminobutyric acid (GABA) transaminase in isolated leukocytes and evidence that GABA and beta-alanine transaminases are identical. Clinical chemistry 20010301
Chronic elevation of brain GABA levels beginning two days after status epilepticus does not prevent epileptogenesis in rats. Neuropharmacology 20010301
Placental transfer of vigabatrin (gamma-vinyl GABA) and its effect on concentration of amino acids in the embryo of TO mice. Teratology 20010301
Prolonged epileptic blindness in an infant associated with cortical dysplasia. Developmental medicine and child neurology 20010201
Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom. Epilepsia 20010201
Visual field loss associated with vigabatrin: quantification and relation to dosage. Epilepsia 20010201
Determination of the antiepileptics vigabatrin and gabapentin in dosage forms and biological fluids using Hantzsch reaction. Arzneimittel-Forschung 20010201
The effect of gamma-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat. Pharmacology, biochemistry, and behavior 20010201
Increased vigabatrin entry into the brain by polysorbate 80 and sodium caprate. The Journal of pharmacy and pharmacology 20010201
Infantile spasms. Pediatric neurology 20010201
[Antiepileptic drugs and neuropathic pain]. Revista de neurologia 20010201
Revised guideline for prescribing vigabatrin in children. Guideline's claim about infantile spasms is not based on appropriate evidence. BMJ (Clinical research ed.) 20010127
[Vigabatrin and visual fields defects]. Ugeskrift for laeger 20010108
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V). Epilepsy research 20010101
The wide field multifocal ERG reveals a retinal defect caused by vigabatrin toxicity. The British journal of ophthalmology 20010101
Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics. Epilepsia 20010101
The role of vigabatrin in childhood seizure disorders: results from a clinical audit. Epilepsia 20010101
[Evaluation of extensive visual field defects with computer-assisted kinetic perimetry]. Klinische Monatsblatter fur Augenheilkunde 20010101
The use of vigabatrin in infantile spasms in Asian children. Annals of the Academy of Medicine, Singapore 20010101
Update on anticonvulsants for the treatment of alcohol withdrawal. The American journal on addictions 20010101
New developments in the pharmacotherapy of alcohol dependence. The American journal on addictions 20010101
Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression. Pharmacology, biochemistry, and behavior 20010101
The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20010101
Changes in color vision after a single dose of vigabatrin or carbamazepine in healthy volunteers. Clinical neuropharmacology 20010101
Visual field defects and other ophthalmological disturbances associated with vigabatrin. Drug safety 20010101
Effects of antiepileptic drugs on cognition. Epilepsia 20010101
Behavioural effects of the new anticonvulsants. Drug safety 20010101
Visual field defects with vigabatrin: epidemiology and therapeutic implications. CNS drugs 20010101
Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication. Documenta ophthalmologica. Advances in ophthalmology 20010101
The new generation of GABA enhancers. Potential in the treatment of epilepsy. CNS drugs 20010101
Spectrofluorimetric determination of vigabatrin and gabapentin in dosage forms and spiked plasma samples through derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole. Journal of AOAC International 20010101
GABAergic mechanisms in epilepsy. Epilepsia 20010101
Epileptic encephalopathy. Epilepsia 20010101
Management strategies for refractory localization-related seizures. Epilepsia 20010101
The management of refractory idiopathic epilepsies. Epilepsia 20010101
Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications. CNS drugs 20010101
[Social and economic aspects of administration of new antiepileptic drugs]. Neurologia i neurochirurgia polska 20010101
A risk-benefit assessment of treatments for infantile spasms. Drug safety 20010101
Anti-spasticity agents for multiple sclerosis. The Cochrane database of systematic reviews 20010101
Adverse events in medical management--vigabatrin as a paradigm of forensic responsibility with novel therapy. Medicine and law 20010101
Ethical dilemmas of potential adverse events. Medicine and law 20010101
Bodyweight gain and anticonvulsants: a comparative review. Drug safety 20010101
Stiff-Baby--an unusual manifestation of cytoplasmic body myopathy: report of one case. Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi 20010101
[New antiepileptic drugs in childhood epilepsies: indications and limits]. Epileptic disorders : international epilepsy journal with videotape 20010101
Isobolographic analysis of interaction between vigabatrin and baclofen in the formalin test in mice. Polish journal of pharmacology 20010101
[West syndrome--new therapeutic approach]. Srpski arhiv za celokupno lekarstvo 20010101
[Visual field changes secondary to vigabatrin treatment]. Revista de neurologia 20001201
Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction. Epilepsia 20001101
Visual field defects in patients taking vigabatrin. Acta ophthalmologica Scandinavica 20001001
[[Acute encephalopathy and myoclonic status induced by vigabatrin monotherapy] ]. Neurologia (Barcelona, Spain) 20001001
Human brain GABA transaminase tissue distribution and molecular expression. European journal of biochemistry 20000901
Visual function loss from vigabatrin: effect of stopping the drug. Neurology 20000712
Visual impairment in children with epilepsy treated with vigabatrin. Annals of neurology 20000701
Effect of long-term vigabatrin administration on the immature rat brain. Epilepsia 20000601
Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables. Seizure 20000601
Vigabatrin-associated visual field defects in children. Eye (London, England) 20000601
Another case of reversibility of visual-field defect induced by vigabatrin monotherapy: is young age a favorable factor? Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20000601
Visual field defect associated with vigabatrin. Many more patients may be affected than were found in study. BMJ (Clinical research ed.) 20000520
A controlled study of vigabatrin and visual abnormalities. The British journal of ophthalmology 20000501
Concentric contraction of the visual field in patients with temporal lobe epilepsy and its association with the use of vigabatrin medication. Epilepsia 20000501
Acute encephalopathy associated with vigabatrin in a six-month-old girl. Epilepsia 20000501
Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy. Ophthalmology 20000501
Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Annals of neurology 20000201
Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings. Neurology 19991210
Characteristics of a unique visual field defect attributed to vigabatrin. Epilepsia 19991201
Visual field defect associated with vigabatrin: observational cohort study. BMJ (Clinical research ed.) 19991030
Psychiatric adverse events during vigabatrin therapy. Neurology 19991022
Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures. The Journal of pharmacology and experimental therapeutics 19990901
Elimination of oxcarbazepine-induced oculogyric crisis following vagus nerve stimulation. Neurology 19990610
GABA changes with vigabatrin in the developing human brain. Epilepsia 19990401
Pharmacokinetics of antiepileptic drugs. Neurology 19981101
[Influence of co-administered antiepileptic drugs on nitrazepam tolerance in mice]. No to hattatsu = Brain and development 19981101
A novel strategy for the treatment of cocaine addiction. Synapse (New York, N.Y.) 19981001
Inappropriate use of carbamazepine and vigabatrin in typical absence seizures. Developmental medicine and child neurology 19980801
Antiepileptic drug-induced worsening of seizures in children. Epilepsia 19980101
Effectiveness of vigabatrin against focally evoked pilocarpine-induced seizures and concomitant changes in extracellular hippocampal and cerebellar glutamate, gamma-aminobutyric acid and dopamine levels, a microdialysis-electrocorticography study in freely moving rats. The Journal of pharmacology and experimental therapeutics 19971201
Identification and characterization of the vesicular GABA transporter. Nature 19971023
A quantitative study of daytime sleepiness induced by carbamazepine and add-on vigabatrin in epileptic patients. Acta neurologica Scandinavica 19970401
Teratogenic effects of vigabatrin in TO mouse fetuses. Teratology 19970301
Amphetamine and vigabatrin down regulate aromatic L-amino acid decarboxylase mRNA levels. Brain research. Molecular brain research 19960101
Adrenocorticotropic hormone and vigabatrin treatment of children with infantile spasms underlying cerebral palsy. Brain & development 19960101
Vigabatrin-associated reversible acute psychosis in a child. The Annals of pharmacotherapy 19951101
Suppression of haloperidol-induced oral dyskinesias in rats by vigabatrin. Pharmacology, biochemistry, and behavior 19950201
Bipolar affective psychosis after vigabatrin. Lancet (London, England) 19940305
[Allergic vasculitis caused by Vigabatrin]. Der Nervenarzt 19940201
[Subsequent manic disorder due to combination vigabatrin-clomipramine]. L'Encephale 19940101
Acute encephalopathy with vigabatrin. Lancet (London, England) 19930717
GABA metabolism in the substantia nigra, cortex, and hippocampus during status epilepticus. Neurochemical research 19930401
Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry 19920501
Relative anticonvulsant effects of GABAmimetic and GABA modulatory agents. Epilepsia 19920101
Experimental studies of the influence of vigabatrin on the GABA system. British journal of clinical pharmacology 19890101
Suppression of methionine sulfoximine seizures by intranigral gamma-vinyl GABA injection. European journal of pharmacology 19870604
Susceptibility to seizures produced by pilocarpine in rats after microinjection of isoniazid or gamma-vinyl-GABA into the substantia nigra. Brain research 19860409
Effects of inhibitors of GABA-transaminase on hole-board exploration and on temperature. Relation with effects on quasi-morphine abstinence behaviour induced by sodium dipropylacetate. Biochemical pharmacology 19851101
Effect of elevated brain GABA concentrations on the actions of bicuculline and picrotoxin in mice. Psychopharmacology 19771020
4-amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. European journal of biochemistry 19770415
Properties